Bio-Rad Laboratories (BIO) Q1 2024 Earnings
BIO·Reported May 7, 2024·After market close
Bio-Rad Laboratories reported Q1 2024 revenue of $610.8M, missed analyst consensus of $619.1M by $8.3M. Diluted EPS came in at $2.29, beat the $2.15 consensus by $0.14.
Revenue
$610.8Mmissed by $8.3M
Consensus: $619.1MDiluted EPS
$2.29beat by $0.14
Consensus: $2.15
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Bio-Rad Laboratories's Q1 2024 earnings report.
Bio-Rad Laboratories (BIO) reported Q1 2024 earnings on May 7, 2024 after market close.
Bio-Rad Laboratories reported revenue of $610.8M and diluted EPS of $2.29 for Q1 2024.
Revenue missed the consensus estimate of $619.1M by $8.3M. EPS beat the consensus estimate of $2.15 by $0.14.
You can read the 10-Q periodic report (0000012208-24-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.